Literature DB >> 31308097

RGS4 Maintains Chronic Pain Symptoms in Rodent Models.

Kleopatra Avrampou1,2, Kerri D Pryce1, Aarthi Ramakrishnan1, Farhana Sakloth1, Sevasti Gaspari1, Randal A Serafini1, Vasiliki Mitsi1, Claire Polizu1, Cole Swartz1, Barbara Ligas1, Abigail Richards1, Li Shen1, Fiona B Carr1, Venetia Zachariou3,4.   

Abstract

Regulator of G-protein signaling 4 (RGS4) is a potent modulator of G-protein-coupled receptor signal transduction that is expressed throughout the pain matrix. Here, we use genetic mouse models to demonstrate a role of RGS4 in the maintenance of chronic pain states in male and female mice. Using paradigms of peripheral inflammation and nerve injury, we show that the prevention of RGS4 action leads to recovery from mechanical and cold allodynia and increases the motivation for wheel running. Similarly, RGS4KO eliminates the duration of nocifensive behavior in the second phase of the formalin assay. Using the Complete Freud's Adjuvant (CFA) model of hindpaw inflammation we also demonstrate that downregulation of RGS4 in the adult ventral posterolateral thalamic nuclei promotes recovery from mechanical and cold allodynia. RNA sequencing analysis of thalamus (THL) from RGS4WT and RGS4KO mice points to many signal transduction modulators and transcription factors that are uniquely regulated in CFA-treated RGS4WT cohorts. Ingenuity pathway analysis suggests that several components of glutamatergic signaling are differentially affected by CFA treatment between RGS4WT and RGS4KO groups. Notably, Western blot analysis shows increased expression of metabotropic glutamate receptor 2 in THL synaptosomes of RGS4KO mice at time points at which they recover from mechanical allodynia. Overall, our study provides information on a novel intracellular pathway that contributes to the maintenance of chronic pain states and points to RGS4 as a potential therapeutic target.SIGNIFICANCE STATEMENT There is an imminent need for safe and efficient chronic pain medications. Regulator of G-protein signaling 4 (RGS4) is a multifunctional signal transduction protein, widely expressed in the pain matrix. Here, we demonstrate that RGS4 plays a prominent role in the maintenance of chronic pain symptoms in male and female mice. Using genetically modified mice, we show a dynamic role of RGS4 in recovery from symptoms of sensory hypersensitivity deriving from hindpaw inflammation or hindlimb nerve injury. We also demonstrate an important role of RGS4 actions in gene expression patterns induced by chronic pain states in the mouse thalamus. Our findings provide novel insight into mechanisms associated with the maintenance of chronic pain states and demonstrate that interventions in RGS4 activity promote recovery from sensory hypersensitivity symptoms.
Copyright © 2019 the authors.

Entities:  

Keywords:  RGS; RNA sequencing; genetic mouse models; inflammatory pain; neuropathic pain; viral gene transfer

Year:  2019        PMID: 31308097      PMCID: PMC6794935          DOI: 10.1523/JNEUROSCI.3154-18.2019

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  81 in total

1.  Differential modulation of nociceptive neural responses in medial and lateral pain pathways by peripheral electrical stimulation: a multichannel recording study.

Authors:  Jin-Yan Wang; Han-Ti Zhang; Ji-Sheng Han; Jing-Yu Chang; Donald J Woodward; Fei Luo
Journal:  Brain Res       Date:  2004-07-16       Impact factor: 3.252

2.  RGS4 is required for dopaminergic control of striatal LTD and susceptibility to parkinsonian motor deficits.

Authors:  Talia N Lerner; Anatol C Kreitzer
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

Review 3.  Central modulation of pain.

Authors:  Michael H Ossipov; Gregory O Dussor; Frank Porreca
Journal:  J Clin Invest       Date:  2010-11-01       Impact factor: 14.808

Review 4.  In search of analgesia: emerging roles of GPCRs in pain.

Authors:  Laura S Stone; Derek C Molliver
Journal:  Mol Interv       Date:  2009-10

5.  Microcircuit Mechanisms through which Mediodorsal Thalamic Input to Anterior Cingulate Cortex Exacerbates Pain-Related Aversion.

Authors:  Karuna S Meda; Tosha Patel; Joao M Braz; Ruchi Malik; Marc L Turner; Helia Seifikar; Allan I Basbaum; Vikaas S Sohal
Journal:  Neuron       Date:  2019-04-25       Impact factor: 17.173

6.  Intrathecal RGS4 inhibitor, CCG50014, reduces nociceptive responses and enhances opioid-mediated analgesic effects in the mouse formalin test.

Authors:  Seo-Yeon Yoon; Jiwan Woo; Joon-Oh Park; Eui-Ju Choi; Hee-Sup Shin; Dae-Hyun Roh; Key-Sun Kim
Journal:  Anesth Analg       Date:  2015-03       Impact factor: 5.108

7.  Role of thalamic phospholipase C[beta]4 mediated by metabotropic glutamate receptor type 1 in inflammatory pain.

Authors:  Mariko Miyata; Hideki Kashiwadani; Masahiro Fukaya; Takayuki Hayashi; Dianqing Wu; Tutomu Suzuki; Masahiko Watanabe; Yoriko Kawakami
Journal:  J Neurosci       Date:  2003-09-03       Impact factor: 6.167

8.  PI3K contributed to modulation of spinal nociceptive information related to ephrinBs/EphBs.

Authors:  Li-Na Yu; Xue-Long Zhou; Jing Yu; Hao Huang; Li-Shan Jiang; Feng-Jiang Zhang; Jun-Li Cao; Min Yan
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

9.  HTSeq--a Python framework to work with high-throughput sequencing data.

Authors:  Simon Anders; Paul Theodor Pyl; Wolfgang Huber
Journal:  Bioinformatics       Date:  2014-09-25       Impact factor: 6.937

10.  Morphine-induced hyperalgesia involves mu opioid receptors and the metabolite morphine-3-glucuronide.

Authors:  Laurie-Anne Roeckel; Valérie Utard; David Reiss; Jinane Mouheiche; Hervé Maurin; Anne Robé; Emilie Audouard; John N Wood; Yannick Goumon; Frédéric Simonin; Claire Gaveriaux-Ruff
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

View more
  10 in total

1.  Age-Induced Changes in μ-Opioid Receptor Signaling in the Midbrain Periaqueductal Gray of Male and Female Rats.

Authors:  Evan F Fullerton; Mary C Karom; John M Streicher; Larry J Young; Anne Z Murphy
Journal:  J Neurosci       Date:  2022-07-05       Impact factor: 6.709

2.  Estrogen modulation of the pronociceptive effects of serotonin on female rat trigeminal sensory neurons is timing dependent and dosage dependent and requires estrogen receptor alpha.

Authors:  Sukhbir Kaur; Taylor M Hickman; Angela Lopez-Ramirez; Hanna McDonald; Lauren M Lockhart; Omar Darwish; Dayna Loyd Averitt
Journal:  Pain       Date:  2022-02-02       Impact factor: 7.926

3.  HDAC6-selective inhibitors decrease nerve-injury and inflammation-associated mechanical hypersensitivity in mice.

Authors:  Farhana Sakloth; Lefteris Manouras; Kleopatra Avrampou; Vasiliki Mitsi; Randal A Serafini; Kerri D Pryce; Valeria Cogliani; Olivier Berton; Matthew Jarpe; Venetia Zachariou
Journal:  Psychopharmacology (Berl)       Date:  2020-05-09       Impact factor: 4.415

Review 4.  Regulator of G-Protein Signaling (RGS) Protein Modulation of Opioid Receptor Signaling as a Potential Target for Pain Management.

Authors:  Nicolas B Senese; Ram Kandasamy; Kelsey E Kochan; John R Traynor
Journal:  Front Mol Neurosci       Date:  2020-01-24       Impact factor: 5.639

5.  Macrophage regulator of G-protein signaling 12 contributes to inflammatory pain hypersensitivity.

Authors:  Gongsheng Yuan; Shuting Yang; Mayank Gautam; Wenqin Luo; Shuying Yang
Journal:  Ann Transl Med       Date:  2021-03

6.  A peptide blocking the ADORA1-neurabin interaction is anticonvulsant and inhibits epilepsy in an Alzheimer's model.

Authors:  Shalini Saggu; Yunjia Chen; Liping Chen; Diana Pizarro; Sandipan Pati; Wen Jing Law; Lori McMahon; Kai Jiao; Qin Wang
Journal:  JCI Insight       Date:  2022-06-08

7.  SARS-CoV-2 Airway Infection Results in Time-dependent Sensory Abnormalities in a Hamster Model.

Authors:  Randal A Serafini; Justin J Frere; Jeffrey Zimering; Ilinca M Giosan; Kerri D Pryce; Ilona Golynker; Maryline Panis; Anne Ruiz; Benjamin tenOever; Venetia Zachariou
Journal:  bioRxiv       Date:  2022-08-19

8.  A promising chemical series of positive allosteric modulators of the μ-opioid receptor that enhance the antinociceptive efficacy of opioids but not their adverse effects.

Authors:  Kerri D Pryce; Hye Jin Kang; Farhana Sakloth; Yongfeng Liu; Susan Khan; Katalin Toth; Abhijeet Kapoor; Andrew Nicolais; Tao Che; Lihuai Qin; Feodora Bertherat; H Ümit Kaniskan; Jian Jin; Michael D Cameron; Bryan L Roth; Venetia Zachariou; Marta Filizola
Journal:  Neuropharmacology       Date:  2021-06-18       Impact factor: 5.273

Review 9.  'Reinventing the wheel' to advance the development of pain therapeutics.

Authors:  Ram Kandasamy; Michael M Morgan
Journal:  Behav Pharmacol       Date:  2021-04-01       Impact factor: 2.277

10.  Synergistic regulation of Rgs4 mRNA by HuR and miR-26/RISC in neurons.

Authors:  Janina Ehses; Sandra M Fernández-Moya; Luise Schröger; Michael A Kiebler
Journal:  RNA Biol       Date:  2020-08-11       Impact factor: 4.652

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.